-+ 0.00%
-+ 0.00%
-+ 0.00%

Sonoma Pharmaceuticals Reports 18% Revenue Increase, 43% Decrease in Net Loss Per Share for Q1 Fiscal 2026

Reuters·08/07/2025 20:16:15

Please log in to view news